Month: January 2024

Inaugural TELUS AI report surveys Canadian attitudes towards the potential impact and evolution of artificial intelligence, Canadians want diverse voices to shape AI TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) — Today, as the world marks Data Privacy Week, TELUS is proud to highlight its leadership in driving dialogue and collaboration around the responsible development and application of artificial intelligence (AI) by sharing the inaugural TELUS AI report: The power of perspectives in Canada. In this research report, available to the public at telus.com/ResponsibleAI, TELUS shares the perceptions, insights and opinions of AI from nearly 5,000 Canadians, including Indigenous Peoples, racialized groups, Black women, older Canadians, new Canadians, youth, people with physical disabilities, and the LGBTQ2S+ community. TELUS’ report highlights...

Detroit, Jan. 25, 2024 (GLOBE NEWSWIRE) — DTE Energy (NYSE:DTE) will announce its full year 2023 earnings before the market opens Thursday, Feb. 8, 2024. The company will conduct a conference call to discuss earnings results at 9 a.m. ET the same day. Investors, the news media and the public may listen to a live internet broadcast of the call at dteenergy.com/investors. The telephone dial-in number in the U.S. and Canada toll free is: (888) 510-2008 or international toll: (646) 960-0306. The passcode is 4987588. The webcast will be archived on the DTE Energy website at dteenergy.com/investors. About DTE Energy DTE Energy (NYSE:DTE) is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services nationwide. Its operating units include an electric company serving...

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference: 4th How to Diagnose and Treat Acute Leukaemias, taking place March 1-3, 2024, in Stockholm, Sweden. The presentation details are below: Title: Phase 1 Dose-Escalation Study of GFH009 in Acute Myeloid LeukemiaSession Date and Time: Sunday, March 3, 2024, at 12 pm CETSession Title: Leukemia Treatment Challenges Presenter: Dr....

Podcasts Combine for Over 700 Million Downloads and Over 7000 Episodes Carolla Set for Induction into the Podcast Hall of Fame During 2024 Podfest Expo LOS ANGELES, CA, Jan. 25, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), which owns ~80% of the PODC outstanding common stock, announced today that it entered into a new agreement with podcast host and revered comedian, Adam Carolla, for his long running The Adam Carolla Podcast and for The Adam and Dr. Drew Show. Carolla is set for induction into the 6th Annual Podcast Hall of Fame during Podfest Expo later this month. The Podcast Hall of fame celebrates the outstanding individuals who have left an indelible mark on the podcasting industry. Since 2009, The Adam Carolla Podcast with its...

Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase assets from C2 Wellness Corporation. (“C2”), a Wyoming registered company with an address at 30 N Gould St, Ste R, Sheridan, WY, that owns certain platform technologies and associated intellectual property invented and developed by the scientific team of C2. The purchase is for 5 million shares of common stock of Bright Green Corporation payable to all shareholders of C2. The implementation of the transaction has been approved by the board of both companies. The primary assets relate to:Novel cannabinoid molecules and their associated intellectual property; Novel cannabinoid prodrugs, and their associated intellectual property; Novel proprietary cannabinoid formulations, designed to target lymphatic...

Conduent chosen to provide technologies and services to retrieve motor vehicle registration ownership data, building on current OTA relationship reviewing license plate images Solutions will support OTA’s plan to convert its entire tolling system to cashless, benefiting motorists and the environment FLORHAM PARK, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) — Conduent Transportation, a global provider of smart mobility technology solutions and business unit of Conduent Incorporated (Nasdaq: CNDT), today announced its selection by the Oklahoma Turnpike Authority (OTA) to provide technologies and services to support the state’s PlatePay cashless tolling system. Conduent will accurately and securely retrieve registration ownership data for vehicles, enabling invoices to be sent to motorists who travel through tolls without a PIKEPASS transponder....

While 91% have launched AI proofs of concept, only 36% are using widely across business functions NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) — The largest financial services firms and insurance carriers are all-in on artificial intelligence (AI), with the vast majority (91%) launching point solutions and proofs of concept over the last year. However, according to new research conducted by EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, challenges with accessing siloed data and concerns about risks associated with the technology are preventing large-scale, enterprise-wide integration. The research, published in a report entitled 2024 EXL Enterprise AI Study: Bridging Strategy and Operations is based on a survey of 158 C-suite and other senior decision makers engaged in strategy, technology...